Asfar S Azmi

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 20

Top Venues

Cancers

International journal of molecular sciences

Nature reviews. Clinical oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Wayne State University School of Medicine

Aligarh Muslim University Faculty of Life Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Wayne State University School of Medicine Sep 01 2014

United States

Assistant Professor :: Oncology

Wayne State University School of Medicine Nov 12 2006

United States

Research Scientist :: Pathology

Education History

Aligarh Muslim University Faculty of Life Sciences May 12 2002 - Aug 12 2006

India

PHD :: Biochemistry

Publications

Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, Osama Alkhalili, Mohammed H Uddin, Sahar F Bannoura, Yousef Mzannar, Ibrahim Hanna Azar, Eliza Wright Beal, Miguel Tobon, Steve H Kim, Rafic Beydoun, Erkan Baloglu, William Senapedis, Bassel F El-Rayes, Philip A Philip, Ramzi M Mohammad, Anthony Frank Shields, Mohammad Najeeb Al-Hallak, Asfar S Azmi
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers. Molecular cancer therapeutics (2023)
Jessica Elderkin, Najeeb Al Hallak, Asfar S Azmi, Hussein Aoun, Jeffrey Critchfield, Miguel Tobon, Eliza Wright Beal
Hepatocellular Carcinoma: Surveillance, Diagnosis, Evaluation and Management. Cancers 15 (21) (2023)
Sahar F Bannoura, Amro Aboukameel, Husain Yar Khan, Mohammed H Uddin, Hyejeong Jang, Eliza Wright Beal, Amalraj Thangasamy, Seongho Kim, Kay-Uwe Wagner, Ramzi M Mohammad, Mohammad Najeeb Al-Hallak, Boris C Pasche, Asfar S Azmi
Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis. bioRxiv : the preprint server for biology (2023)
Misako Nagasaka, Asfar S Azmi
Clinical progress of KRAS-targeted therapies: what next? Future medicinal chemistry 14 (15) (2022)
Amr Mohamed, Asfar S Azmi, Sylvia L Asa, Sree Harsha Tirumani, Amit Mahipal, Sakti Cjakrabarti, David L Bajor, J Eva Selfridge, Ahmed Omar Kaseb
Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel Combination. Current oncology (Toronto, Ont.) 29 (11) (2022)
Lorenzo F Sempere, Asfar S Azmi, Anna Moore
microRNA-based diagnostic and therapeutic applications in cancer medicine. Wiley interdisciplinary reviews. RNA 12 (6) (2021)
Yiwei Li, Mohammed Najeeb Al Hallak, Philip A Philip, Asfar S Azmi, Ramzi M Mohammad
Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs. Cancers 13 (16) (2021)
Husain Yar Khan, Mohammed H Uddin, Suresh Kumar Balasubramanian, Noor Sulaiman, Marium Iqbal, Mahmoud Chaker, Amro Aboukameel, Yiwei Li, William Senapedis, Erkan Baloglu, Ramzi M Mohammad, Jeffrey Zonder, Asfar S Azmi
PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma. Cancers 14 (1) (2021)
Erlene K Seymour, Husain Yar Khan, Yiwei Li, Mahmoud Chaker, Irfana Muqbil, Amro Aboukameel, Radhakrishanan Ramchandren, Christiane Houde, Golbon Sterbis, Jay Yang, Divaya Bhutani, Silvana Pregja, Kathy Reichel, Amy Huddlestun, Colleen Neveux, Kelly Corona, Yosef Landesman, Jatin Shah, Michael Kauffman, Sharon Shacham, Ramzi M Mohammad, Asfar S Azmi, Jeffrey A Zonder
Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (12) (2021)
Gabriel B Mpilla, Mohammed H Uddin, Mohammed N Al-Hallak, Amro Aboukameel, Yiwei Li, Steve H Kim, Rafic Beydoun, Gregory Dyson, Erkan Baloglu, William T Senapedis, Yosef Landesman, Kay-Uwe Wagner, Nerissa T Viola, Bassel F El-Rayes, Philip A Philip, Ramzi M Mohammad, Asfar S Azmi
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus. Molecular cancer therapeutics 20 (10) (2021)
Mohammed H Uddin, Yiwei Li, Husain Yar Khan, Irfana Muqbil, Amro Aboukameel, Rachel E Sexton, Shriya Reddy, Yosef Landesman, Trinayan Kashyap, Asfar S Azmi, Elisabeth I Heath
Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer Cells. International journal of molecular sciences 22 (13) (2021)
Mohammed H Uddin, Mohammed Najeeb Al-Hallak, Philip A Philip, Ramzi M Mohammad, Nerissa Viola, Kay-Uwe Wagner, Asfar S Azmi
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside. Cancers 13 (11) (2021)
Asfar S Azmi, Mohammed H Uddin, Ramzi M Mohammad
The nuclear export protein XPO1 - from biology to targeted therapy. Nature reviews. Clinical oncology 18 (3) (2020)
Asfar S Azmi, Mohammed H Uddin, Ramzi M Mohammad
Author Correction: The nuclear export protein XPO1 - from biology to targeted therapy. Nature reviews. Clinical oncology (2020)
Husain Yar Khan, Gabriel B Mpilla, Rachel Sexton, Srikant Viswanadha, Kumar V Penmetsa, Amro Aboukameel, Maria Diab, Mandana Kamgar, Mohammad Najeeb Al-Hallak, Mark Szlaczky, Anteneh Tesfaye, Steve Kim, Philip A Philip, Ramzi M Mohammad, Asfar S Azmi
Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth. Cancers 12 (3) (2020)
Rachel E Sexton, Mohammed Najeeb Al Hallak, Maria Diab, Asfar S Azmi
Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer metastasis reviews 39 (4) (2020)
Gabriel B Mpilla, Amro Aboukameel, Irfana Muqbil, Steve H Kim, Rafic Beydoun, Philip A Philip, Ramzi M Mohammad, Mandana Kamgar, Vinod Shidham, William Senapedis, Erkan Baloglu, Jing Li, Gregory Dyson, Yue Xue, Bassel El-Rayes, Asfar S Azmi
PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors. Cancers 11 (12) (2019)
Rachel Sexton, Zaid Mahdi, Rahman Chaudhury, Rafic Beydoun, Amro Aboukameel, Husain Y Khan, Erkan Baloglu, William Senapedis, Yosef Landesman, Anteneh Tesfaye, Steve H Kim, Philip A Philip, Asfar S Azmi
Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer. International journal of molecular sciences 20 (19) (2019)
Asfar S Azmi, Husain Yar Khan, Irfana Muqbil, Amro Aboukameel, Jasper Edgar Neggers, Dirk Daelemans, Amit Mahipal, Gregory Dyson, Mandana Kamgar, Mohammad Najeeb Al-Hallak, Anteneh A Tesfaye, Steve H Kim, Vinod Shidham, Ramzi M Mohammad, Philip A Philip
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (6) (2019)
Husain Yar Khan, James Ge, Misako Nagasaka, Amro Aboukameel, Gabriel B Mpilla, Irfana Muqbil, Mark Szlaczky, Mahmoud Chaker, Erkan Baloglu, Yosef Landesman, Ramzi M Mohammad, Asfar S Azmi, Ammar Sukari
Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance. International journal of molecular sciences 21 (1) (2019)

Asfar S Azmi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Asfar S Azmi